New stock news | Overwhelmingly raising 77.6 billion in IPO, oversubscribed 1133 times! Shougang Longze (02553) IPO closes.

date
12:46 31/05/2026
avatar
GMT Eight
Leading company in the CCUS industry Shougang Langze (02553) will begin its IPO on May 26-29, 2026, with unprecedented market subscription enthusiasm.
Leading company in the CCUS industry, Shougang Langze (02553), started its IPO from May 26th to 29th, 2026, and the market subscription sentiment was unprecedentedly hot. According to TRADEGO data, as of 4 pm on May 29th, the margin financing for the public offering section totaled as high as 77.592 billion Hong Kong dollars, calculated based on the total fund raised of 0.684 billion Hong Kong dollars, with an oversubscription rate of 1133.38 times. Futu Securities led the pack with 44.847 billion Hong Kong dollars, followed by Huili Securities and Tiger International with 16.1 billion and 7.457 billion Hong Kong dollars respectively, showing a very strong lead by the main brokerage firms. Shougang Langze's global offering this time is 40 million H-shares, with 10% for public offering in Hong Kong and 15% for over-allotment option. The company expects to be listed on the Hong Kong Stock Exchange on June 3rd at 9 am. As the first company in the CCUS (carbon capture, utilization, and storage) industry to scale up the commercialization of low-carbon products using verified synthetic biology technology, Shougang Langze holds a solid leading position with 58.4% of the global market share based on projected revenue for 2025. The company has core technologies of "first-generation carbon reduction + second-generation negative carbon", converting exhaust gases from steel and iron alloy industries directly into high-value products such as ethanol and microbial protein. Its core technology has received international RSB certification and been recognized by the International Energy Agency as a successful case of advanced transport biofuels. With the first domestic "Provisional Certificate for Feed Protein" and SAF opening up the second growth pole, the company is well-positioned for sustained growth. The company's microbial protein has been awarded the first domestic certificate for feed raw materials by the Ministry of Agriculture and Rural Affairs, with a crude protein content of over 80%, more than 15% higher than fish meal. At the same time, the company is actively involved in the sustainable aviation fuel (SAF) track, with the first SAF facility with an annual production capacity of about 50,000 tons expected to be operational in 2027, tapping into the global SAF market (with a compound annual growth rate of 41.6% from 2025 to 2030). Prior to listing, Shougang Langze has received strategic investments from well-known institutions such as Caofeidian Fund, Mitsui & Co., Ltd., and Shanghai Guomen. On the production capacity side, the Hebei Shoulang Phase II project, using second-generation negative carbon technology, is expected to start trial production in June 2026 with a carbon sequestration rate of up to 93.5%. With the continuous strengthening of "dual carbon" policies and ESG investments becoming mainstream, Shougang Langze, with its rare technological barriers and clear path to commercialization, has long-term tracking value.